The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis
Open accessAbstract
Advanced hepatic fibrosis, driven by the activation of hepatic stellate cells (HSCs), affects millions worldwide and is the strongest predictor of mortality in nonalcoholic steatohepatitis (NASH); however, there are no approved antifibrotic therapies. To identify antifibrotic drug targets, we integrated progressive transcriptomic and morphological responses that accompany HSC activation in advanced disease using single-nucleus RNA sequencing and tissue clearing in a robust murine NASH model. In advanced fibrosis, we found that an autocrine HSC signaling circuit emerged that was composed of 68 receptor-ligand interactions conserved between murine and human NASH. These predicted interactions were supported by the parallel appearance of markedly increased direct stellate cell-cell contacts in murine NASH. As proof of principle, pharmacological inhibition of one such autocrine interaction, neurotrophic receptor tyrosine kinase 3–neurotrophin 3, inhibited human HSC activation in culture and reversed advanced murine NASH fibrosis. In summary, we uncovered a repertoire of antifibrotic drug targets underlying advanced fibrosis in vivo. The findings suggest a therapeutic paradigm in which stage-specific therapies could yield enhanced antifibrotic efficacy in patients with advanced hepatic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent single-cell human liver studies have largely focused on chronic liver disease rather than ALF, with emphasis on non-parenchymal cell populations7–9”
From Multimodal decoding of human liver regeneration (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“the FAT-MASH model was used, as this model reproducibly recapitulates the stages of progression of human MASH that include advanced fibrosis and tumors along with changes in the gut microbiome.14,33,34”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [33]
In the citing paper
“We recently used single nuclear RNA-seq in murine MASH models and patients with MASH to demonstrate enrichment of pathways in myofibroblasts that regulate extracellular matrix production and cell migration, including matrix metalloproteinase (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and lysyl oxidases (LOXLs) (47-49), similar to earlier studies of mouse fibrosis and human cirrhosis”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“Our profiling of FAT-MASH macrophages using single nucleus RNA-seq showed no enrichment of ECM-related pathways, only induction of a few select matrix metalloproteinases (MMP2, matrix metalloproteinase 12 (MMP12), matrix metalloproteinase 14 (MMP14)) and decreased collagen type 18 alpha 1 (COL18A1) (48).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“The detection of both quiescent and activated HSCs in mouse liver injury models using single cell RNA-seq reinforces HSC activation as a driver of fibrosis common across etiologies that includes MASH (46-50).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“Although activated HSCs are the primary fibrogenic cells in MASH, these methods have identified an expanded list of fibrogenic drivers expressed by activated HSCs that could represent antifibrotic drug targets (42, 48, 49, 125).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“These different communication networks are reflected in the differential expression of ligand-receptor signaling pairs, suggesting that the repertoire of disease drivers – and therefore the underlying signaling events – may change as the disease advances, such that advanced fibrotic stages may respond to different pharmacotherapies than earlier stages (48, 49).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“Applying recent developments in informatic tools and databases (130, 131) has uncovered an altered cell-cell communication network in MASH based on the differential expression of ligands and receptors in different cell types (48, 49).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“It is worth noting that the FAT-MASH mice exhibit transcriptomic similarities to human MASH patients (48), and their microbiome changes also resemble human MASH pathology (197).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“To improve the quantitative measurement of fibrosis in liver biopsies, several robust platforms have been established that leverage machine or deep learning to precisely quantify not only the amount of scar, but also structural features of the extracellular matrix that may reflect progression or regression (48, 258, 290, 291).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“3) Identification of HSC subpopulations that are the main fibrosis drivers will lead to more targeted, safer therapies (42, 48).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [48]
In the citing paper
“In advanced (human or rodent) hepatic fibrosis, HSC directly interacts with surrounding HSCs, driven by autocrine pathways that amplify fibrogenesis.112”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Self-citationEfremova, M., Vento-Tormo, M., Teichmann, S. A., & Vento-Tormo, R. (2020) · Nature Protocols · doi:10.1038/s41596-020-0292-x · Cited by 3,449
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Self-citationiDISCO: A Simple, Rapid Method to Immunolabel Large Tissue Samples for Volume Imaging
Renier, N., Wu, Z., Simon, D. J., Yang, J. H., Ariel, P., & Tessier‐Lavigne, M. (2014) · Cell · doi:10.1016/j.cell.2014.10.010 · Cited by 1,856
Cross-tissue organization of the fibroblast lineage
Buechler, M. B., Pradhan, R., Krishnamurty, A. T., Cox, C. B., Calviello, A. K., Wang, A. W., Yang, Y. A., Tam, L., Caothien, R. H., Roose‐Girma, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03549-5 · Cited by 1,100
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
Xu, L., Hui, A. Y., Albanis, E., Arthur, M. J., O’Byrne, S. M., Blaner, W. S., Mukherjee, P., Friedman, S. L., & Eng, F. J. (2004) · Gut · doi:10.1136/gut.2004.042127 · Cited by 1,020
Self-citationSpatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Guilliams, M., Bonnardel, J., Haest, B., Vanderborght, B., Wagner, C., Remmerie, A., Bujko, A., Martens, L., Thoné, T., Browaeys, R., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.018 · Cited by 985
Vilar-Gomez, E., Calzadilla-Bertot, L., Wai-Sun Wong, V., Castellanos, M., Aller-de la Fuente, R., Metwally, M., Eslam, M., Gonzalez-Fabian, L., Alvarez-Quiñones Sanz, M., Conde-Martin, A. F., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.034 · Cited by 806
Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–176 of 176
Zhao, J., Peng, Y., Lei, H., Wang, T., Wang, H., Wang, B., Li, J., Li, X., & Xiong, X. (2026) · Advanced Science · doi:10.1002/advs.202514545 · Cited by 4
NAT10 promotes the activation of hepatic stellate cells by modulating the TGF-β1-ac4C-COL1A1 axis
Zhang, A., Zhang, Y., Guan, F., Shi, J., Abudula, N., Shao, X., Qi, Q., Liu, W., Xia, T., & Shi, C. (2026) · Hepatology International · doi:10.1007/s12072-025-10998-x · Cited by 4
Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options
Ren, R., Liang, X., & Wei, X. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00486-5 · Cited by 5
Procollagen 1 assembles into phase-separated condensates in the endoplasmic reticulum
Bhattacharyya, S. S., Wojnacki, J., Brouwers, N., & Malhotra, V. (2026) · The Journal of Cell Biology · doi:10.1083/jcb.202603129 · Cited by 5
Hong, J. G., Carbajal, Y., Trotman, J. C., Glass, M., Sclar, V., Alter, I. L., Zhang, P., Wang, L., Chen, L., Petitjean, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.17.576067 · Cited by 4
Self-citationQuantifying fibrosis in inflammatory bowel diseases – contribution of digital pathology
Jerala, M., Chen, L., Drobne, D., Petitjean, M. M., & Zidar, N. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.08.002 · Cited by 3
Self-citationRole of Scar‐Associated Macrophages in Organ Fibrosis Diseases
Ding, R., Yang, Z., Chen, Y., Yu, Q., Ji, Y., Wang, Z., & Gu, M. (2026) · Journal of Immunology Research · doi:10.1155/jimr/8393673 · Cited by 3
Hepatic stellate cells regulate multiple aspects of hepatocyte function in health and disease
Ramachandran, P. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.05.017 · Cited by 3
Liu, L., Du, H., Wu, F., Li, C., Chen, J., Zhang, X., Zhu, Q., & Li, X. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.07.035 · Cited by 3
Wang, Y., Yu, H., Cen, Z., Zhu, Y., & Wu, W. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100267 · Cited by 3
Interaction of high lipogenic states with titanium on osteogenesis
Pinto, T. S., van der Eerden, B. C. J., Schreuders‐Koedam, M., van de Peppel, J., Ayada, I., Pan, Q., Verstegen, M. M. A., van der Laan, L. J. W., Fuhler, G. M., Zambuzzi, W. F., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117242 · Cited by 3
Resolvin D1-mediated cellular crosstalk protects against MASH
Navarro‐Corcuera, A., Zhu, Y., Ma, F., Gupta, N., Asplund, H., Cogliati, B., Chipuk, J. E., Rom, O., Friedman, S. L., Sansbury, B. E., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101454 · Cited by 7
Self-citationDuc, P. M., Thủy, L. T. T., Hai, H., Hà, N. T. T., Anh, P. T., Ikenaga, H., Fuji, H., Yuasa, H., Matsubara, T., Huyen, V. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.12.657772 · Cited by 3
Self-citationGao, M., Wen, Z., Zhang, X., Guo, Z., & Jiang, Y. (2026) · Nanotechnology · doi:10.1088/1361-6528/ae435b · Cited by 2
Duc, P. M., Thủy, L. T. T., Hai, H., Bao, T. V., Ha, N. T., Anh, P. T., Ikenaga, H., Fujii, H., Yoshida, K., Enomoto, M., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101783 · Cited by 5
Self-citationZhao, X., Wang, C., Fan, Z., Kong, Q., Feng, L., & Qin, L. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04457-4 · Cited by 3
Xu, H., Yang, L., Fang, P., Sun, J., Zhong, X., Deng, W., Li, S., Zhou, L., Fan, J., Zhang, D., et al. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000928 · Cited by 2
Molecular mechanisms and pathogenesis of MASH
Gallage, S., Govaere, O., Anstee, Q. M., Shulman, G. I., Tacke, F., & Heikenwälder, M. F. (2026) · Nature · doi:10.1038/s41586-026-10529-0 · Cited by 3
Stopping stellate cell communication reverses fibrosis
Crunkhorn, S. (2023) · Nature Reviews Drug Discovery · doi:10.1038/d41573-023-00016-w · Cited by 2
Tracking of Stem Cells in Chronic Liver Diseases: Current Trends and Developments
He, J.-L., You, Y.-X., Xiong, P., Jiang, W., Zeng, Q., Chen, B., Wang, Y., Chen, E., Tang, H., Gao, X.-F., et al. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10659-2 · Cited by 2
Hepatitis B virus induced cirrhosis and hepatocarcinoma: pathogenesis and therapeutics
Yao, J., Guo, J., & Xie, Y. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100565 · Cited by 3
Hong, J. G., Trotman, J. C., Carbajal, Y., Dey, P., Glass, M., Sclar, V., Alter, I. L., Zhang, P., Wang, L., Chen, L., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000671 · Cited by 5
Self-citationMa, X., Li, B., Liu, Y., & Guo, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1534200 · Cited by 2
Ma, W., Zhong, X., Cai, B., Shao, M., Yu, X., Lv, M., Xu, S., Zhan, B., Li, Q., Ma, M., et al. (2023) · medRxiv · doi:10.1101/2023.10.05.23296635 · Cited by 2
Therapeutic Activity of Resolvin D1 (RvD1) in Murine MASHPreprint
Navarro‐Corcuera, A., Zhu, Y., Ma, F., Gupta, N., Asplund, H., Yuan, F., Friedman, S., Sansbury, B. E., Huang, X. H., & Cai, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.22.590633 · Cited by 2
Self-citationMiyara, S., Frenkel, S., Mayo, A., Gascard, P. D., Strasser, M., Gibbs, D. L., Weizman, E., Shalom, I., Stein, Y., Pan, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.25.668405 · Cited by 2
Self-citationCampos, M. A. J., Stroggilos, R., Schanstra, J. P., Vlahou, A., Brunet, M., Jonas, J., Bensellam, M., Mischak, H., & Latosińska, A. (2025) · medRxiv · doi:10.1101/2025.10.07.25337472 · Cited by 2
Nagaraj, M., Emmagouni, S. K. G., Chaurasiya, V., Li, L., Nguyen, V. D., Keskitalo, S., Varjosalo, M. T., Zhou, Y., Haridas, P. A. N., & Olkkonen, V. M. (2025) · FEBS Letters · doi:10.1002/1873-3468.70001 · Cited by 2
Luo, X., Deng, H., Li, Q., Zhao, M., Zhang, Y., Guo, J., Wen, Y., Chen, G.-S., & Li, J.-Q. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141919 · Cited by 1
Virzì, A., Boulahtouf, Z., Moehlin, J., Girard, L., Heydmann, L., Bach, C., Gerges, E., Durand, S., Oudot, M. A., Suarez, A. A. R., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-09870-7 · Cited by 3
Dragomiretskaya, N. A., Volchkov, I. I., Белов, А. В., Gontsova, L. A., Vetluzhskaya, M. V., & Podzolkov, V. I. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6397 · Cited by 1
α1-acid Glycoprotein mitigates MASLD progression by modulating liver and adipose tissue function
Nishinoiri, A., Tokumaru, K., Kanazawa, G., Shintani, Y., Yoshitake, T., Yamamoto, T., Fukuta, S., Nishimura, A., Nishida, M., Takeo, T., et al. (2026) · Endocrinology · doi:10.1210/endocr/bqag009
Ratziu, V., Petitjean, L., Pais, R., Aron‐Wisnewsky, J., Charlotte, F., Bédossa, P., Thabut, D., Kara, L., Clément, K., & Petitjean, M. M. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000900 · Cited by 1
Self-citationYang, A., Yan, X., Wang, Y., Han, Q., Tong, X., Chen, S., Zhao, X., Chen, W., Jia, J., Schuppan, D., et al. (2026) · Hepatology · doi:10.1097/hep.0000000000001715 · Cited by 1
Wang, T., Zhu, X., Zhang, Y., Su, L., & Pan, T. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101048 · Cited by 1
Yang, X.-X., Dong, Q., Ma, J., Yan, Y., Peng, S.-Y., Wu, Q., Wang, H., Zhang, T., Zhang, P., Jiang, Z., et al. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70675 · Cited by 1
Fallowfield, J. A., Ramachandran, P., & Kendall, T. J. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.05.026 · Cited by 2
Li, Y., Wang, Y., Tong, C., Fu, X., Ma, N., Hao, Y., Feng, Z., Ling, S., Yin, Z., Li, H., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci203412 · Cited by 1
Papachristoforou, E., Kong, K., Colella, F., Tam, J., Luft, J., Parhar, R., Liang, Y., McCafferty-Brown, A., Finney, G. E., Rao, K., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02774-w · Cited by 8
Self-citationAutocrine signalling discovery reveals potential therapeutic targets in NASH fibrosis
Fyfe, I. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00749-4 · Cited by 1
Regulation of Female Reproductive Aging by the Spag17 GenePreprint
Ericsson, V., Elam, M., Sapao, P., Nguyen, L. M. T., Gill, M. E., Chodavarapu, S., Córdova‐Fletes, C., Lafrenaye, A. D., Hassan, S. S., Mahendroo, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.01.640648 · Cited by 1
Self-citationProteinaceous Metal-Binding Eph-Ephrin Tetramerization is Modulated by Copper and ChelatorsPreprint
Khambete, A., Wang, H., & Henkemeyer, M. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.08.693004 · Cited by 1
Cholesterol-associated Locus EHBP1 Protects against NASH FibrosisPreprint
Ma, F., Longo, M., Huang, X., Meroni, M., Prakash, S., Paolini, E., Bhattacharya, D., Wang, S., Wang, X., Mughal, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.08.548218
Self-citationAnstee, Q. M. (2023) · PubMed Central
The liver sinusoid at single-cell level
Parhar, R., & Ramachandran, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00006-1
Development of Therapy for Liver Fibrosis: Molecular/cellular basis and overcoming challenges
Inagaki, Y., & Yanagawa, T. (2024) · Kanzo · doi:10.2957/kanzo.65.305
Mathematical Modelling of MASLD ‐ Towards Digital Twins in Liver Disease
Simonsson, C. (2024) · Linköping studies in science and technology. Dissertations · doi:10.3384/9789180757348
Single Cell Transcriptomics Reveal Genomic Indicators of Nonalcoholic Fatty Liver DiseasePreprint
Thakur, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.04.621970
Chin, S. E., Gallego, P., Aagaard, A., Carmen, S., Barrett, N., Wolny, M., Cloarec, S., Paterson, J., Sivapalan, R., Hunt, J., et al. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100216
Vu, H., Sun, Y., Xiong, Z., Radford‐Smith, D. E., Causer, A., Nefzger, C. M., O'Sullivan, E. D., Watt, M. J., Ramm, G. A., Clouston, A. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.20.644239
Jiang, R., Dai, L., Xu, X., & Zhang, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02588-5
Endothelial and stromal cell contributions to salivary gland injury and repair
Altrieth, A. L. (2023) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/9tzg-v00s
A minimal model of PTSD susceptibility and timescales
Grosskopf, Y., Danan, D., Mayo, A., Doenyas-Barak, K., & Alon, U. S. (2026) · iScience · doi:10.1016/j.isci.2026.116391
Self-citationIdentification of a potential target for autoimmune hepatitis: SNHG7
Pang, X., Cui, S., & Wang, F. (2025) · Medicine · doi:10.1097/md.0000000000043991
Bando, T., Sato, H., Uno, S., Morita, H., Zreka, L., Ma, S., Khan, M., Akuzawa, D., Masuo, Y., Matsuyama, J., et al. (2025) · International Immunology · doi:10.1093/intimm/dxaf055
Yoshigi, M., Kamdem, S. D., Wang, H., Khambete, A., Sprouse, F., Kameni, E. M., Atiogue, E., Pellizzari, S., Evason, K. J., Helms, M. N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.19.688968
Self-citationWang, J., Tao, J., Xia, C., Tang, M., Stoica, A.-F., Yuan, S., Li, Y., Guo, L., Kong, X., & Wang, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.25.690307
Gao, R., Chen, H., Wang, J., Xu, L., Li, F., Jiang, X., Geng, X., Li, N., Chaulagain, R. P., Oluwaseun, B. D., et al. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71144
Ding, S., Liu, Y., Liu, Z., Chu, F., Lu, B., & Xu, L. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s569506
Chrono-metabolic regulation of hepatic fibrosis via NR1D1-mediated hepatic stellate cell activation
Tu, H.-S., Chen, M.-L., Hong, J., & He, L. (2026) · World Journal of Hepatology · doi:10.4254/wjh.118194
Briand, F., Grasset, E., Shinohara, M., Cordeiro, L., Richard, V., Endlich, N., Endlich, T., Chen, L., Petitjean, M., de Bel, T., et al. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107588
Self-citationSheng, W., Zhang, Z., Song, D., Shen, Y., Zhang, X., Xiang, Y., Lu, L., Li, C., Liu, C., Ji, G., et al. (2026) · Liver International · doi:10.1111/liv.70755
Microtechnologies for biological research: From cell culture to drug screening
Fernandes, T., Fernandes, P., & Marques, M. P. C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36330-6.00005-9
Jiang, W., Wei, W., Tu, S., Yan, J., & Yan, X. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026138
Labrecque, C. L., Ko, A., Qiao, B., Pan, C., Nandakumar, R., Chowdhury, K., Venkatesan, N., Du, X., Cai, B., Pellegrini, M. A., et al. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000001015 · Cited by 1
Zhang, T., Zhang, H., Wang, S., Yang, X., Qiu, X., & Zhang, Q. (2026) · Research Square · doi:10.21203/rs.3.rs-10543780/v1
Self-citationRecent advances and prospects in smart optical nanoprobes for precision detection of liver diseases
Zhang, Y., Chen, X., Wang, X., Zhang, J., & Liang, X. (2026) · Chemical Communications · doi:10.1039/d6cc04229e
Lu, X., & Li, Z. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1912158
Mechanisms of regeneration and maladaptive repair in acute kidney injury
Seibt, T., Hoeft, K., Schaefer, G. J. L., Wahida, A., Kurzrock, R., Conrad, M., & Kramann, R. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01115-8
Intraoperative glucocorticoids confound surgical biopsy transcriptomics
Larsen, F. T., Wernberg, C. W., Nambiar, J., Dutta, S., Nielsen, E. J., Grønkjær, L. L., Jacobsen, B. G., Mandrup, S., Loft, A., Schmidt, S. F., et al. (2026) · JCI Insight · doi:10.64898/2026.09.08.26362140
Local sympathetic signal enables the immune evasion of hepatic stellate cells
Li, T., Zhou, X., Wang, G., Deng, Z., Zhao, Y., Chen, D., Cao, Y., Fu, W., & Yang, J. H. (2026) · Neuron · doi:10.1016/j.neuron.2026.08.016 · Cited by 1
Li, Z., Kwan, X., Liu, Q., Chong, J., Jiang, X., Wang, J., 陈少东, & Liang, H. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48100988
Campos, M. A. J., Stroggilos, R., Schanstra, J. P., Vlahou, A., Brunet, M., Jonas, J., Bensellam, M., Mischak, H., & Latosińska, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198755 · Cited by 1
Chen, R., Yang, Y., Chen, G., Cai, X., Lu, L., & Ge, Q. (2026) · Journal of Translational Gastroenterology · doi:10.14218/jtg.2026.00026
刘连勇, Hu, G., Gu, F., Zhu, Q., Li, C., Di, X., Zou, M., & Li, X. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04553-1
Zhang, J., Wang, J., Shen, Y., Zhang, Y., Luo, Z., Kong, X., Li, W., Luo, J., Xu, F., & Wan, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1961567
Metadata
- Authors
- Wang, S., Li, K., Pickholz, E., Dobie, R., Matchett, K. P., Henderson, N. C., Carrico, C., Driver, I., Borch Jensen, M., Chen, L., Petitjean, M., Bhattacharya, D., Fiel, M. I., Liu, X., Kisseleva, T., Alon, U., Adler, M., Medzhitov, R., & Friedman, S. L.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Centre for Inflammation Research (GB)
- Gordian Biotechnology, San Francisco, CA 94107, USA.
- PharmaNest Inc., Princeton, NJ 08540, USA.
- University of California San Diego (US)
- Weizmann Institute of Science (IL)
- Yale University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Friedman, Scott L.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2023-01-04
- Volume
- 15
- Issue
- 677
- Pages
- eadd3949-eadd3949
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC10686705
- OpenAlex
- W4313544888
- Cited by
- 176
- References
- 31
- Citations by year
- 2026: 43 · 2025: 51 · 2024: 40 · 2023: 41
- FWCI
- 29.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Gastroenterological Association
- Wellcome Trust (219542/Z/19/Z)
- Cancer Research UK (A27145, 27145, C19767/A27145)
- National Institutes of Health (DK120515, UL1TR004419)
- National Institute on Alcohol Abuse and Alcoholism (U01AA029019, R01AA028550, P50AA011999)
- National Cancer Institute (P30CA196521)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK111866, R01DK056621, R01DK128289, R01DK136016, P30DK120515, R01DK101737, R01DK099205)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- hepatic stellate cells, nonalcoholic steatohepatitis, liver fibrosis, autocrine signaling, ligand-receptor interactions, NTRK3, neurotrophin-3, stellate cell activation, single-nucleus RNA sequencing, tissue clearing
- MeSH terms
- Animals, Fibrosis, Humans, Liver, Liver Cirrhosis, Autocrine Communication, Mice, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
